发明名称 TNF-alpha PRODUCTION INHIBITOR
摘要 PROBLEM TO BE SOLVED: To provide a TNF-αproduction inhibitor useful as a therapeutic agent for autoimmune diseases such as rheumatoid arthritis. SOLUTION: The novel compound having a structure represented by general formula [1] [wherein A is -(NR<SP>4</SP>)-, -(CR<SP>5</SP>R<SP>6</SP>)- or -O-; B is an alkylene or alkenylene group; R<SP>1</SP>, R<SP>2</SP>, R<SP>4</SP>, R<SP>5</SP>and R<SP>6</SP>are each a hydrogen atom, an alkyl group, an alkenyl group, an adamantylalkyl group or the like; R<SP>3</SP>is an aryl group or an unsaturated heterocyclic group; and X is an oxygen or sulfur atom] and salts thereof have excellent TNF-αproduction inhibitory activities. COPYRIGHT: (C)2006,JPO&NCIPI
申请公布号 JP2006213739(A) 申请公布日期 2006.08.17
申请号 JP20060140241 申请日期 2006.05.19
申请人 SANTEN PHARMACEUT CO LTD 发明人 BAN MASAKAZU;SUHARA HIROSHI;HORIUCHI MASATO;YAMAMOTO GOKO;ENOMOTO HIROSHI;INOUE HIROYUKI
分类号 C07D213/36;C07D233/61;A61K31/16;A61K31/18;A61K31/417;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4418;A61K31/4425;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4436;A61K31/4439;A61K31/4525;A61K31/4545;A61K31/4709;A61K31/4725;A61K31/496;A61K31/513;A61K31/5377;A61P29/00;A61P37/00;A61P37/06;A61P43/00;C07C275/24;C07C311/39;C07D213/30;C07D213/32;C07D213/38;C07D213/40;C07D213/55;C07D213/56;C07D213/59;C07D213/68;C07D213/74;C07D213/75;C07D215/12;C07D401/06;C07D401/12;C07D405/12;C07D409/12;C07D417/12;C07D487/04 主分类号 C07D213/36
代理机构 代理人
主权项
地址